FDA applicant
Spectrum Antimicrobials, Inc. (Subsidiary of Collidion, Inc.
FDA records 1 decision for Spectrum Antimicrobials, Inc. (Subsidiary of Collidion, Inc. (Petaluma, CA) in 2023: 1 510(k) clearance. All are in product code FRO (Dressing, Wound, Drug). Its devices cite 1 predicate, 0 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Spectrum Antimicrobials, Inc. (Subsidiary of Collidion, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2023.
Planning a device like Spectrum Antimicrobials, Inc.…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Spectrum”
FDA records each applicant name separately; these may or may not be the same firm.